(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 4.85% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Biote's revenue in 2025 is $199,073,000.On average, 4 Wall Street analysts forecast BTMD's revenue for 2025 to be $9,521,270,753, with the lowest BTMD revenue forecast at $9,415,620,031, and the highest BTMD revenue forecast at $9,596,071,662. On average, 5 Wall Street analysts forecast BTMD's revenue for 2026 to be $10,254,102,130, with the lowest BTMD revenue forecast at $9,272,741,891, and the highest BTMD revenue forecast at $11,618,118,705.
In 2027, BTMD is forecast to generate $11,516,521,965 in revenue, with the lowest revenue forecast at $10,030,638,741 and the highest revenue forecast at $13,002,405,189.